Our starting sources.
Original documents behind our educational guidance. These resources are not treatment endorsements. Reviewed November 1, 2026; check each document for updates.
FDA: BPC-157 safety considerations ↗The agency’s discussion of evidence gaps and quality concernsHHS: peptide compounding policy notice ↗The October 30, 2026 Federal Register notice and policy linkFDA: understanding compounded medicines ↗How compounding differs from FDA approval